Announcements Trials
Browse Landscape

Status

Completed 142Recruiting 69Terminated 43Unknown 30Active not recruiting 19Withdrawn 7Not yet recruiting 5Available 4Suspended 2Enrolling by invitation 2No longer available 1Approved for marketing 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 1Gynecologic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 15Carcinoma, Renal Cell 4Urinary Bladder Neoplasms 2Rhabdoid Tumor 2Wilms Tumor 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Prostatic Neoplasms, Castration-Resistant 1Progressive Metastatic Castrate Resistant Prostate Cancer 1Pinealoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Mesothelioma, Malignant 1Meningeal Neoplasms 1Melanoma 1Medulloblastoma 1Lung Neoplasms 1Kidney Neoplasms 1Hepatoblastoma 1Disease 1Desmoplastic Small Round Cell Tumor 1Colorectal Neoplasms 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pegilodecakin 1AM0010 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Pancreatic Neoplasms × Genitourinary × Clear all
NCT03554434 2020-03-02

An Expanded Access Program for AM0010 (Pegilodecakin)

Eli Lilly and Company

No longer available
BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡